Abstract
An experimental murine infection was established by the intraperitoneal injection of a log-phase culture of a laboratory reference strain of Streptococcus agalactiae, Lancefield group B, type III (strain SS620), suspended in sterile hog gastric mucin. The enhancement of streptococcal virulence was measured by a significantly increased mortality in outbred ICR Swiss mice. An inbred C57BL6 strain of mice was resistant to the mucin-bacterial combination. Mucin, treated with Desferal to chelate the iron, did not lose the capacity to enhance the virulence of group B, type III streptococci in ICR Swiss mice. Iron-dextran was not a suitable substitute for mucin and failed to enhance the virulence of group B, type III streptococci. The results of these studies indicate that iron is not the resistance-lowering factor in this group B, type III streptococci-mucin model.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andrews B. S., Theofilopoulos A. N. A microassay for the determination of hemolytic complement activity in mouse serum. J Immunol Methods. 1978;22(3-4):273–281. doi: 10.1016/0022-1759(78)90035-2. [DOI] [PubMed] [Google Scholar]
- Baker C. J., Kasper D. L. Microcapsule of type III strains of group B Streptococcus: production and morphology. Infect Immun. 1976 Jan;13(1):189–194. doi: 10.1128/iai.13.1.189-194.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baltimore R. S., Kasper D. L., Vecchitto J. Mouse protection test for group B Streptococcus type III. J Infect Dis. 1979 Jul;140(1):81–88. doi: 10.1093/infdis/140.1.81. [DOI] [PubMed] [Google Scholar]
- Berden J. H., Hagemann J. F., Koene R. A. A sensitive haemolytic assay of mouse complement. J Immunol Methods. 1978;23(1-2):149–159. doi: 10.1016/0022-1759(78)90118-7. [DOI] [PubMed] [Google Scholar]
- Calver G. A., Kenny C. P., Lavergne G. Iron as a replacement for mucin in the establishment of meningococcal infection in mice. Can J Microbiol. 1976 Jun;22(6):832–838. doi: 10.1139/m76-120. [DOI] [PubMed] [Google Scholar]
- Chandra R. K. Reduced bactericidal capacity of polymorphs in iron deficiency. Arch Dis Child. 1973 Nov;48(11):864–866. doi: 10.1136/adc.48.11.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edwards M. S., Baker C. J., Wagner M. L., Taber L. H., Barrett F. F. An etiologic shift in infantile osteomyelitis: the emergence of the group B streptococcus. J Pediatr. 1978 Oct;93(4):578–583. doi: 10.1016/s0022-3476(78)80891-9. [DOI] [PubMed] [Google Scholar]
- Fox L., Sprunt K. Neonatal osteomyelitis. Pediatrics. 1978 Oct;62(4):535–542. [PubMed] [Google Scholar]
- Lancefield R. C., McCarty M., Everly W. N. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med. 1975 Jul 1;142(1):165–179. doi: 10.1084/jem.142.1.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller C. P. EXPERIMENTAL MENINGOCOCCAL INFECTION IN MICE. Science. 1933 Oct 13;78(2024):340–341. doi: 10.1126/science.78.2024.340. [DOI] [PubMed] [Google Scholar]
- Weinberg E. D. Iron and infection. Microbiol Rev. 1978 Mar;42(1):45–66. doi: 10.1128/mr.42.1.45-66.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wennerstrom D. E., Schutt R. W. Adult mice as a model for early onset group B streptococcal disease. Infect Immun. 1978 Feb;19(2):741–744. doi: 10.1128/iai.19.2.741-744.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkinson H. W., Eagon R. G. Type-specific antigens of group B type Ic streptococci. Infect Immun. 1971 Nov;4(5):596–604. doi: 10.1128/iai.4.5.596-604.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkinson H. W. Group B streptococcal infection in humans. Annu Rev Microbiol. 1978;32:41–57. doi: 10.1146/annurev.mi.32.100178.000353. [DOI] [PubMed] [Google Scholar]